{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:16:41Z","timestamp":1792088201342,"version":"4.4.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"5-6","license":[{"start":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T00:00:00Z","timestamp":1710288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T00:00:00Z","timestamp":1710288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["grant no. 81402181"],"award-info":[{"award-number":["grant no. 81402181"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Natural Science Foundation of Shandong Province","award":["grant no. ZR2023MH105"],"award-info":[{"award-number":["grant no. ZR2023MH105"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Apoptosis"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s10495-024-01944-7","type":"journal-article","created":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T16:36:13Z","timestamp":1710347773000},"page":"743-756","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["FAM83B regulates mitochondrial metabolism and anti-apoptotic activity in pulmonary adenocarcinoma"],"prefix":"10.1007","volume":"29","author":[{"given":"Jiajia","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panpan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,13]]},"reference":[{"key":"1944_CR1","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1309\/AJCP1QUQQLLT8BLI","volume":"142","author":"J de Castro","year":"2014","unstructured":"de Castro J, Rodriguez MC, Martinez-Zorzano VS, Sanchez-Rodriguez P, Sanchez-Yague J (2014) Erythrocyte fatty acids as potential biomarkers in the diagnosis of advanced lung adenocarcinoma, lung squamous cell carcinoma, and small cell lung cancer. Am J Clin Pathol 142:111\u2013120","journal-title":"Am J Clin Pathol"},{"key":"1944_CR2","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature25183","volume":"553","author":"RS Herbst","year":"2018","unstructured":"Herbst RS, Morgensztern D, Boshoff C (2018) The biology and management of non-small cell lung cancer. Nature 553:446\u2013454","journal-title":"Nature"},{"key":"1944_CR3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21442","volume":"68","author":"RL Siegel","year":"2018","unstructured":"Siegel RL, Miller KD, Jemal A (2018) Cancer statistics, 2018. CA Cancer J Clin 68:7\u201330","journal-title":"CA Cancer J Clin"},{"key":"1944_CR4","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/nrc3775","volume":"14","author":"Z Chen","year":"2014","unstructured":"Chen Z, Fillmore CM, Hammerman PS, Kim CF, Wong KK (2014) Non-small-cell lung cancers: a heterogeneous set of diseases. Nat Rev Cancer 14:535\u2013546","journal-title":"Nat Rev Cancer"},{"key":"1944_CR5","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s10555-007-9049-z","volume":"26","author":"YG Assaraf","year":"2007","unstructured":"Assaraf YG (2007) Molecular basis of antifolate resistance. Cancer Metastasis Rev 26:153\u2013181","journal-title":"Cancer Metastasis Rev"},{"key":"1944_CR6","doi-asserted-by":"publisher","first-page":"854","DOI":"10.3349\/ymj.2013.54.4.854","volume":"54","author":"M Jung","year":"2013","unstructured":"Jung M et al (2013) Pharmacogenomic assessment of outcomes of pemetrexed-treated patients with adenocarcinoma of the lung. Yonsei Med J 54:854\u2013864","journal-title":"Yonsei Med J"},{"issue":"531","key":"1944_CR7","doi-asserted-by":"publisher","first-page":"eaao2341","DOI":"10.1126\/scisignal.aao2341","volume":"11","author":"LJ Fulcher","year":"2018","unstructured":"Fulcher LJ et al (2018) The DUF1669 domain of FAM83 family proteins anchor casein kinase 1 isoforms. Sci Signal 11(531):eaao2341","journal-title":"Sci Signal"},{"key":"1944_CR8","doi-asserted-by":"publisher","first-page":"999","DOI":"10.3892\/ijo.2015.2817","volume":"46","author":"N Okabe","year":"2015","unstructured":"Okabe N et al (2015) FAM83B is a novel biomarker for diagnosis and prognosis of lung squamous cell carcinoma. Int J Oncol 46:999\u20131006","journal-title":"Int J Oncol"},{"issue":"5","key":"1944_CR9","doi-asserted-by":"publisher","first-page":"652","DOI":"10.3390\/cancers11050652","volume":"11","author":"S Richtmann","year":"2019","unstructured":"Richtmann S et al (2019) FAM83A and FAM83B as prognostic biomarkers and potential new therapeutic targets in NSCLC. Cancers (Basel) 11(5):652","journal-title":"Cancers (Basel)"},{"key":"1944_CR10","first-page":"1549","volume":"15","author":"T Yamaura","year":"2018","unstructured":"Yamaura T et al (2018) Family with sequence similarity 83, member B is a predictor of poor prognosis and a potential therapeutic target for lung adenocarcinoma expressing wild-type epidermal growth factor receptor. Oncol Lett 15:1549\u20131558","journal-title":"Oncol Lett"},{"key":"1944_CR11","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12890-022-02303-5","volume":"23","author":"J Zhang","year":"2023","unstructured":"Zhang J et al (2023) FAM83B promotes the invasion of primary lung adenocarcinoma via PI3K\/AKT\/NF-kappaB pathway. BMC Pulm Med 23:32","journal-title":"BMC Pulm Med"},{"key":"1944_CR12","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s004180050202","volume":"109","author":"S Bertschy","year":"1998","unstructured":"Bertschy S, Genton CY, Gotzos V (1998) Selective immunocytochemical localisation of calretinin in the human ovary. Histochem Cell Biol 109:59\u201366","journal-title":"Histochem Cell Biol"},{"key":"1944_CR13","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1038\/ncb1063","volume":"5","author":"D Boehning","year":"2003","unstructured":"Boehning D et al (2003) Cytochrome c binds to inositol (1,4,5) trisphosphate receptors, amplifying calcium-dependent apoptosis. Nat Cell Biol 5:1051\u20131061","journal-title":"Nat Cell Biol"},{"key":"1944_CR14","doi-asserted-by":"publisher","first-page":"101076","DOI":"10.1016\/j.redox.2018.101076","volume":"25","author":"J Hirpara","year":"2019","unstructured":"Hirpara J et al (2019) Metabolic reprogramming of oncogene-addicted cancer cells to OXPHOS as a mechanism of drug resistance. Redox Biol 25:101076","journal-title":"Redox Biol"},{"key":"1944_CR15","doi-asserted-by":"publisher","first-page":"3197","DOI":"10.1172\/JCI60517","volume":"122","author":"R Cipriano","year":"2012","unstructured":"Cipriano R et al (2012) FAM83B mediates EGFR- and RAS-driven oncogenic transformation. J Clin Invest 122:3197\u20133210","journal-title":"J Clin Invest"},{"key":"1944_CR16","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1158\/0008-5472.CAN-16-2074","volume":"77","author":"L Yu","year":"2017","unstructured":"Yu L et al (2017) Modeling the genetic regulation of Cancer Metabolism: interplay between Glycolysis and oxidative phosphorylation. Cancer Res 77:1564\u20131574","journal-title":"Cancer Res"},{"issue":"24","key":"1944_CR17","doi-asserted-by":"publisher","first-page":"13435","DOI":"10.3390\/ijms222413435","volume":"22","author":"CL Chen","year":"2021","unstructured":"Chen CL, Lin CY, Kung HJ (2021) Targeting mitochondrial OXPHOS and their regulatory signals in prostate cancers. Int J Mol Sci 22(24):13435","journal-title":"Int J Mol Sci"},{"key":"1944_CR18","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.cmet.2017.10.013","volume":"26","author":"C Bosc","year":"2017","unstructured":"Bosc C, Selak MA, Sarry JE (2017) Resistance is futile: targeting mitochondrial energetics and metabolism to Overcome Drug Resistance in Cancer Treatment. Cell Metab 26:705\u2013707","journal-title":"Cell Metab"},{"key":"1944_CR19","doi-asserted-by":"publisher","first-page":"152817","DOI":"10.1016\/j.prp.2020.152817","volume":"216","author":"M Matsuda","year":"2020","unstructured":"Matsuda M et al (2020) Calretinin-expressing lung adenocarcinoma: distinct characteristics of advanced stages, smoker-type features, and rare expression of other mesothelial markers are useful to differentiate epithelioid mesothelioma. Pathol Res Pract 216:152817","journal-title":"Pathol Res Pract"},{"key":"1944_CR20","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.ccell.2018.10.005","volume":"34","author":"CL Jones","year":"2018","unstructured":"Jones CL et al (2018) Inhibition of amino acid metabolism selectively targets human leukemia stem cells. Cancer Cell 34:724\u2013740e724","journal-title":"Cancer Cell"},{"key":"1944_CR21","doi-asserted-by":"publisher","first-page":"a004051","DOI":"10.1101\/cshperspect.a004051","volume":"2","author":"B Schwaller","year":"2010","unstructured":"Schwaller B (2010) Cytosolic Ca2\u2009+\u2009buffers. Cold Spring Harb Perspect Biol 2:a004051","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"1944_CR22","first-page":"559","volume":"100","author":"CE Comin","year":"2014","unstructured":"Comin CE et al (2014) Expression of thrombomodulin, calretinin, cytokeratin 5\/6, D2-40 and WT-1 in a series of primary carcinomas of the lung: an immunohistochemical study in comparison with epithelioid pleural mesothelioma. Tumori 100:559\u2013567","journal-title":"Tumori"},{"key":"1944_CR23","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1038\/ncb1203-1041","volume":"5","author":"MP Mattson","year":"2003","unstructured":"Mattson MP, Chan SL (2003) Calcium orchestrates apoptosis. Nat Cell Biol 5:1041\u20131043","journal-title":"Nat Cell Biol"},{"key":"1944_CR24","doi-asserted-by":"publisher","first-page":"RC67","DOI":"10.1523\/JNEUROSCI.20-07-j0001.2000","volume":"20","author":"NJ Hack","year":"2000","unstructured":"Hack NJ, Wride MC, Charters KM, Kater SB, Parks TN (2000) Developmental changes in the subcellular localization of calretinin. J Neurosci 20:RC67","journal-title":"J Neurosci"},{"key":"1944_CR25","doi-asserted-by":"publisher","first-page":"29663","DOI":"10.1074\/jbc.272.47.29663","volume":"272","author":"B Schwaller","year":"1997","unstructured":"Schwaller B, Durussel I, Jermann D, Herrmann B, Cox JA (1997) Comparison of the Ca2+-binding properties of human recombinant calretinin-22k and calretinin. J Biol Chem 272:29663\u201329671","journal-title":"J Biol Chem"},{"key":"1944_CR26","doi-asserted-by":"publisher","first-page":"e2123247119","DOI":"10.1073\/pnas.2123247119","volume":"119","author":"H Dong","year":"2022","unstructured":"Dong H et al (2022) Mitochondrial calcium uniporter promotes phagocytosis-dependent activation of the NLRP3 inflammasome. Proc Natl Acad Sci U S A 119:e2123247119","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1944_CR27","doi-asserted-by":"publisher","first-page":"e20276","DOI":"10.1371\/journal.pone.0020276","volume":"6","author":"L Stevenson","year":"2011","unstructured":"Stevenson L et al (2011) Calbindin 2 (CALB2) regulates 5-fluorouracil sensitivity in colorectal cancer by modulating the intrinsic apoptotic pathway. PLoS ONE 6:e20276","journal-title":"PLoS ONE"},{"key":"1944_CR28","doi-asserted-by":"publisher","first-page":"146","DOI":"10.4161\/cbt.8.2.7087","volume":"8","author":"Y Wu","year":"2009","unstructured":"Wu Y, Fabritius M, Ip C (2009) Chemotherapeutic sensitization by endoplasmic reticulum stress: increasing the efficacy of taxane against prostate cancer. Cancer Biol Ther 8:146\u2013152","journal-title":"Cancer Biol Ther"},{"key":"1944_CR29","doi-asserted-by":"publisher","first-page":"4509","DOI":"10.1038\/s41467-019-12103-x","volume":"10","author":"AA Lombardi","year":"2019","unstructured":"Lombardi AA et al (2019) Mitochondrial calcium exchange links metabolism with the epigenome to control cellular differentiation. Nat Commun 10:4509","journal-title":"Nat Commun"},{"key":"1944_CR30","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1038\/s41467-022-28597-x","volume":"13","author":"V Farfariello","year":"2022","unstructured":"Farfariello V et al (2022) TRPC3 shapes the ER-mitochondria ca(2+) transfer characterizing tumour-promoting senescence. Nat Commun 13:956","journal-title":"Nat Commun"},{"key":"1944_CR31","doi-asserted-by":"publisher","first-page":"215582","DOI":"10.1016\/j.canlet.2022.215582","volume":"532","author":"R You","year":"2022","unstructured":"You R et al (2022) Metformin sensitizes AML cells to chemotherapy through blocking mitochondrial transfer from stromal cells to AML cells. Cancer Lett 532:215582","journal-title":"Cancer Lett"}],"container-title":["Apoptosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-024-01944-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10495-024-01944-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-024-01944-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T08:14:03Z","timestamp":1714205643000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10495-024-01944-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,13]]},"references-count":31,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["1944"],"URL":"https:\/\/doi.org\/10.1007\/s10495-024-01944-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3837359\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-3654521\/v1","asserted-by":"object"}]},"ISSN":["1360-8185","1573-675X"],"issn-type":[{"value":"1360-8185","type":"print"},{"value":"1573-675X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,13]]},"assertion":[{"value":"4 February 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest related to this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"These procedures were performed in accordance with the ethical standards of the Committee on Human Experimentation of Shandong University Medical Research Ethics Committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Statement"}}]}}